JPWO2021257542A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021257542A5
JPWO2021257542A5 JP2022577490A JP2022577490A JPWO2021257542A5 JP WO2021257542 A5 JPWO2021257542 A5 JP WO2021257542A5 JP 2022577490 A JP2022577490 A JP 2022577490A JP 2022577490 A JP2022577490 A JP 2022577490A JP WO2021257542 A5 JPWO2021257542 A5 JP WO2021257542A5
Authority
JP
Japan
Prior art keywords
seq
antibody
nos
antibody fragment
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022577490A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023531189A5 (https=
JP2023531189A (ja
JP7795206B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/037400 external-priority patent/WO2021257542A1/en
Publication of JP2023531189A publication Critical patent/JP2023531189A/ja
Publication of JP2023531189A5 publication Critical patent/JP2023531189A5/ja
Publication of JPWO2021257542A5 publication Critical patent/JPWO2021257542A5/ja
Priority to JP2025247571A priority Critical patent/JP2026053430A/ja
Application granted granted Critical
Publication of JP7795206B2 publication Critical patent/JP7795206B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022577490A 2020-06-18 2021-06-15 条件的に活性な抗cd46抗体、抗体断片、それらの免疫コンジュゲート及びその使用 Active JP7795206B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025247571A JP2026053430A (ja) 2020-06-18 2025-12-12 条件的に活性な抗cd46抗体、抗体断片、それらの免疫コンジュゲート及びその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063040913P 2020-06-18 2020-06-18
US63/040,913 2020-06-18
PCT/US2021/037400 WO2021257542A1 (en) 2020-06-18 2021-06-15 Conditionally active anti-cd46 antibodies, antibody fragments, their immunoconjugates and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025247571A Division JP2026053430A (ja) 2020-06-18 2025-12-12 条件的に活性な抗cd46抗体、抗体断片、それらの免疫コンジュゲート及びその使用

Publications (4)

Publication Number Publication Date
JP2023531189A JP2023531189A (ja) 2023-07-21
JP2023531189A5 JP2023531189A5 (https=) 2024-06-18
JPWO2021257542A5 true JPWO2021257542A5 (https=) 2024-06-18
JP7795206B2 JP7795206B2 (ja) 2026-01-07

Family

ID=79268294

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022577490A Active JP7795206B2 (ja) 2020-06-18 2021-06-15 条件的に活性な抗cd46抗体、抗体断片、それらの免疫コンジュゲート及びその使用
JP2025247571A Pending JP2026053430A (ja) 2020-06-18 2025-12-12 条件的に活性な抗cd46抗体、抗体断片、それらの免疫コンジュゲート及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025247571A Pending JP2026053430A (ja) 2020-06-18 2025-12-12 条件的に活性な抗cd46抗体、抗体断片、それらの免疫コンジュゲート及びその使用

Country Status (11)

Country Link
US (1) US20230242662A1 (https=)
EP (1) EP4168452A4 (https=)
JP (2) JP7795206B2 (https=)
KR (1) KR20230023800A (https=)
CN (1) CN115702167A (https=)
AU (1) AU2021292486A1 (https=)
CA (1) CA3182384A1 (https=)
IL (1) IL298902A (https=)
MX (1) MX2022016197A (https=)
TW (1) TWI906314B (https=)
WO (1) WO2021257542A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0624500D0 (en) * 2006-12-07 2007-01-17 Istituto Superiore Di Sanito A novel passive vaccine for candida infections
CA2810016A1 (en) * 2010-09-03 2012-03-08 Stem Centrx, Inc. Novel modulators and methods of use
CN107135654B (zh) * 2014-09-12 2021-10-29 加利福尼亚大学董事会 巨胞饮人类抗cd46抗体和靶向癌症疗法
CA2874083C (en) * 2014-12-05 2024-01-02 Universite Laval Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
WO2017078839A1 (en) * 2015-11-02 2017-05-11 Bioatla, Llc Conditionally active polypeptides
KR102873209B1 (ko) * 2016-08-31 2025-10-17 바이오아트라, 인코퍼레이티드 조건부 활성 폴리펩티드 및 이를 제조하는 방법
ES3005158T3 (en) * 2016-11-11 2025-03-14 Univ California Anti-cd46 antibodies and methods of use
CN109535260B (zh) * 2018-11-22 2021-08-10 东南大学 一种靶向cd46的人源嵌合抗原受体及其应用

Similar Documents

Publication Publication Date Title
JP2022513420A5 (https=)
JP2022101693A5 (https=)
JP2021530987A5 (https=)
JP2011501656A5 (https=)
RU2019138067A (ru) Биспецифическое антитело против ox40 и ctla-4
JP2020502271A5 (https=)
CN117946278A (zh) 多特异性抗体及其制备和使用方法
JP7812336B2 (ja) 分子連結法または分子工学のためのタンデムリピートがん標的化ペプチドおよびがんセラノスティクスにおけるその使用
TW201834697A (zh) Her2標靶抗體-藥物結合物之組合療法
JP2021501776A5 (https=)
JP2019524640A5 (https=)
US20230398229A1 (en) Antibody drug conjugates comprising sting agonists, combinations and methods of use
JPWO2020014132A5 (https=)
WO2023034566A1 (en) Anti-dll3 antibodies and uses thereof
US20240124608A1 (en) Methods and materials for treating clonal t cell expansions
JPWO2021257525A5 (https=)
US20240156863A1 (en) Sequential anti-cd19 therapy
WO2018232164A1 (en) Antibody drug conjugates that bind lgr5
JPWO2021123996A5 (https=)
JPWO2021257542A5 (https=)
JPWO2020014327A5 (https=)
JPWO2023061505A5 (https=)
JPWO2021089588A5 (https=)
CN101277716A (zh) 治疗癌症的抗体
US20260014268A1 (en) Drug conjugates of humanized anti pvr antibodies